Allergy & Immunology Doctors in Melbourne, FL Accepting Medicare

3 Allergy & Immunology doctors found. Showing 1 - 3

Dr. Stephen Michael Garramone, M.D. Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 1073 Old Millpond Rd, Melbourne, FL 32940 Phone: 321-253-8098

Phillip W Devoe, M.D. Allergy & Immunology - Allergy Medicare: Not Enrolled in Medicare Practice Location: 1515 Airport Blvd, Melbourne, FL 32901 Phone: 321-951-2709    Fax: 321-952-2829

Mark W Minor, M.D. Allergy & Immunology - Allergy Medicare: Accepting Medicare Assignments Practice Location: 2290 W Eau Gallie Blvd, Ste 205, Melbourne, FL 32935 Phone: 321-757-5550    Fax: 321-255-5552

News Archive

PharmAthene completes 1,500 liter engineering production run for SparVax anthrax vaccine

PharmAthene, Inc. announced today that it has achieved significant progress in the development of its second generation anthrax vaccine, SparVax.

New form of estrogen shows potential as multiple sclerosis drug

UCLA scientists have found the first evidence that a specific form of estrogen can protect the brain from degeneration yet not increase the risk for estrogen-induced cancers of the breast and uterus.

Researchers identify miRNA in blood serum of lung cancer patients

Researchers have identified characteristic patterns of molecules called microRNA in the blood of people with lung cancer that might reveal both the presence and aggressiveness of the disease, and perhaps who is at risk of developing it.

New methods to evaluate how astrocytes contribute to brain function

A study in The Journal of General Physiology presents new methods to evaluate how astrocytes contribute to brain function, paving the way for future exploration of these important brain cells at unprecedented levels of detail.

Amylin submits metreleptin rolling submission BLA for treatment of rare forms of lipodystrophy

Amylin Pharmaceuticals, Inc. today announced that it has submitted the initial sections of a rolling submission for a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for the use of metreleptin to treat diabetes and/or hypertriglyceridemia (high levels of triglycerides in the bloodstream) in patients with rare forms of lipodystrophy.

Read more Medical News

› Verified 1 days ago